P35329 (CD22_MOUSE) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 126.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: B-cell receptor CD22 Alternative name(s): B-lymphocyte cell adhesion molecule Short name=BL-CAM Sialic acid-binding Ig-like lectin 2 Short name=Siglec-2 T-cell surface antigen Leu-14 CD_antigen=CD22 | ||||
| Gene names |
| ||||
| Organism | Mus musculus (Mouse) [Reference proteome] | ||||
| Taxonomic identifier | 10090 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus › Mus![]() |
Protein attributes
| Sequence length | 862 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Mediates B-cell B-cell interactions. May be involved in the localization of B-cells in lymphoid tissues. Binds sialylated glycoproteins; one of which is CD45. Preferentially binds to alpha-2,6-linked sialic acid. The sialic acid recognition site can be masked by cis interactions with sialic acids on the same cell surface. Upon ligand induced tyrosine phosphorylation in the immune response seems to be involved in regulation of B-cell antigen receptor signaling. Plays a role in positive regulation through interaction with Src family tyrosine kinases and may also act as an inhibitory receptor by recruiting cytoplasmic phosphatases via their SH2 domains that block signal transduction through dephosphorylation of signaling molecules. |
| Subunit structure | Interacts with LYN, SYK, PIK3R1/PIK3R2, PLCG1, SHC1, INPP5D and GRB2 upon phosphorylation. May form a complex with INPP5D/SHIP, GRB2 and SHC1. Interacts with PTPN6/SHP-1 upon phosphorylation By similarity. Ref.6 Ref.7 |
| Subcellular location | |
| Tissue specificity | B-lymphocytes. |
| Domain | Contains 3 copies of a cytoplasmic motif that is referred to as the immunoreceptor tyrosine-based inhibitor motif (ITIM). This motif is involved in modulation of cellular responses. The phosphorylated ITIM motif can bind the SH2 domain of several SH2-containing phosphatases. |
| Post-translational modification | Phosphorylated on tyrosine residues by LYN Probable. Ref.5 Ref.6 Ref.7 Phosphorylation of Tyr-777 and Tyr-837 are involved in binding to SYK. Phosphorylation of Tyr-822 is involved in binding to GRB2. Phosphorylation of Tyr-857 is involved in binding to SYK, PLCG2 and PIK3R1/PIK3R2. |
| Sequence similarities | Belongs to the immunoglobulin superfamily. SIGLEC (sialic acid binding Ig-like lectin) family. Contains 6 Ig-like C2-type (immunoglobulin-like) domains. Contains 1 Ig-like V-type (immunoglobulin-like) domain. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Cell adhesion |
| Cellular component | Cell membrane Membrane |
| Coding sequence diversity | Alternative splicing |
| Domain | Immunoglobulin domain Repeat Signal Transmembrane Transmembrane helix |
| Ligand | Lectin |
| PTM | Disulfide bond Glycoprotein Phosphoprotein |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | cell adhesion Inferred from electronic annotation. Source: UniProtKB-KW cell surface receptor signaling pathwayTraceable author statement PubMed 11606382. Source: MGI |
| Cellular_component | external side of plasma membrane Inferred from direct assay PubMed 8418208. Source: MGI integral to plasma membraneInferred from physical interaction PubMed 11606382. Source: MGI |
| Molecular_function | coreceptor activity Traceable author statement PubMed 11606382. Source: MGI |
| Complete GO annotation... | |
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| Grb2 | Q60631 | 3 | EBI-300059,EBI-1688 |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: P35329-1) Also known as: CD22-beta; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: P35329-2) The sequence of this isoform differs from the canonical sequence as follows: 54-115: Missing. | ||||||
| Isoform 3 (identifier: P35329-3) The sequence of this isoform differs from the canonical sequence as follows: 100-133: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 21 | 21 | Potential | ||||||||
| Chain | 22 – 862 | 841 | B-cell receptor CD22 | PRO_0000014874 | |||||||
Regions | |||||||||||
| Topological domain | 22 – 702 | 681 | Extracellular Potential | ||||||||
| Transmembrane | 703 – 721 | 19 | Helical; Potential | ||||||||
| Topological domain | 722 – 862 | 141 | Cytoplasmic Potential | ||||||||
| Domain | 22 – 142 | 121 | Ig-like V-type | ||||||||
| Domain | 147 – 244 | 98 | Ig-like C2-type 1 | ||||||||
| Domain | 251 – 341 | 91 | Ig-like C2-type 2 | ||||||||
| Domain | 346 – 429 | 84 | Ig-like C2-type 3 | ||||||||
| Domain | 434 – 515 | 82 | Ig-like C2-type 4 | ||||||||
| Domain | 520 – 597 | 78 | Ig-like C2-type 5 | ||||||||
| Domain | 608 – 691 | 84 | Ig-like C2-type 6 | ||||||||
| Motif | 775 – 780 | 6 | ITIM motif 1 | ||||||||
| Motif | 835 – 840 | 6 | ITIM motif 2 | ||||||||
| Motif | 855 – 860 | 6 | ITIM motif 3 | ||||||||
Sites | |||||||||||
| Binding site | 124 | 1 | Sialic acid By similarity | ||||||||
Amino acid modifications | |||||||||||
| Modified residue | 777 | 1 | Phosphotyrosine Probable | ||||||||
| Modified residue | 822 | 1 | Phosphotyrosine Probable | ||||||||
| Modified residue | 837 | 1 | Phosphotyrosine Probable | ||||||||
| Modified residue | 857 | 1 | Phosphotyrosine Probable | ||||||||
| Glycosylation | 105 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 116 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 139 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 168 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 265 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 275 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 378 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 408 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 460 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 561 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 589 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Disulfide bond | 41 ↔ 171 | By similarity | |||||||||
| Disulfide bond | 46 ↔ 106 | By similarity | |||||||||
| Disulfide bond | 165 ↔ 229 | By similarity | |||||||||
| Disulfide bond | 272 ↔ 324 | By similarity | |||||||||
| Disulfide bond | 368 ↔ 411 | By similarity | |||||||||
| Disulfide bond | 457 ↔ 499 | By similarity | |||||||||
| Disulfide bond | 544 ↔ 586 | By similarity | |||||||||
| Disulfide bond | 631 ↔ 674 | By similarity | |||||||||
Natural variations | |||||||||||
| Alternative sequence | 54 – 115 | 62 | Missing in isoform 2. | VSP_002532 | |||||||
| Alternative sequence | 100 – 133 | 34 | Missing in isoform 3. | VSP_002533 | |||||||
| Natural variant | 15 | 1 | A → V in strain: BALB/c, C57BL/6, BXSB and MRL. | ||||||||
| Natural variant | 19 | 1 | Q → R in strain: BALB/c, C57BL/6, BXSB and MRL. | ||||||||
| Natural variant | 76 | 1 | K → T in strain: BALB/c, C57BL/6 and MRL. | ||||||||
| Natural variant | 83 – 86 | 4 | KAEP → ATKTEKDPES in strain: BALB/c, C57BL/6, BXSB and MRL. | ||||||||
| Natural variant | 90 – 91 | 2 | PP → LS in strain: BALB/c. | ||||||||
| Natural variant | 94 | 1 | R → G in strain: BALB/c. | ||||||||
| Natural variant | 102 | 1 | S → R in strain: BALB/c, C57BL/6, BXSB and MRL. | ||||||||
| Natural variant | 112 – 114 | 3 | PIR → LIH in strain: BXSB. | ||||||||
| Natural variant | 173 | 1 | E → G in strain: BALB/c, C57BL/6 and MRL. | ||||||||
| Natural variant | 179 | 1 | Q → K in strain: BALB/c, C57BL/6 and MRL. | ||||||||
| Natural variant | 186 | 1 | K → E in strain: BALB/c, C57BL/6 and MRL. | ||||||||
| Natural variant | 190 | 1 | V → I in strain: BALB/c, C57BL/6 and MRL. | ||||||||
| Natural variant | 192 | 1 | P → S in strain: BALB/c, C57BL/6 and MRL. | ||||||||
| Natural variant | 236 | 1 | E → K in strain: BALB/c, C57BL/6 and MRL. | ||||||||
| Natural variant | 241 | 1 | R → C in strain: BALB/c. | ||||||||
| Natural variant | 244 | 1 | R → H in strain: BALB/c and MRL. | ||||||||
| Natural variant | 273 | 1 | R → Q in strain: BXSB. | ||||||||
| Natural variant | 380 | 1 | T → I in strain: BXSB. | ||||||||
| Natural variant | 387 | 1 | P → H in strain: BXSB. | ||||||||
| Natural variant | 403 | 1 | P → L in strain: BXSB. | ||||||||
| Natural variant | 419 | 1 | H → R in strain: BXSB. | ||||||||
| Natural variant | 423 | 1 | D → G in strain: BXSB. | ||||||||
| Natural variant | 482 | 1 | P → S in strain: BXSB. | ||||||||
| Natural variant | 548 | 1 | E → K in strain: BXSB. | ||||||||
| Natural variant | 616 | 1 | S → I in strain: BALB/c. | ||||||||
| Natural variant | 620 | 1 | H → R in strain: BXSB. | ||||||||
| Natural variant | 714 | 1 | C → F in strain: BALB/c. | ||||||||
| Natural variant | 787 | 1 | M → T in strain: BALB/c, C57BL/6, BXSB and MRL. | ||||||||
| Natural variant | 790 | 1 | A → T in strain: C57BL/6. | ||||||||
| Natural variant | 808 | 1 | S → T in strain: BALB/c, BXSB and MRL. | ||||||||
Experimental info | |||||||||||
| Mutagenesis | 822 | 1 | Y → F: Abolishes binding to GRB2. Ref.6 | ||||||||
| Sequence conflict | 87 | 1 | E → G in CAB85611. Ref.3 | ||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| [1] | "Organization of the murine Cd22 locus. Mapping to chromosome 7 and characterization of two alleles." Law C.-L., Torres R.M., Sundberg H.A., Parkhouse R.M., Brannan C.I., Copeland N.G., Jenkins N.A., Clark E.A. J. Immunol. 151:175-187(1993) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Strain: BALB/c and DBA/2J. Tissue: Liver. |
| [2] | "Polymorphisms in the Cd22 gene of inbred mouse strains." Lajaunias F., Ibnou-Zekri N., Fossati Jimack L., Chicheportiche Y., Parkhouse R.M., Mary C., Reininger L., Brighouse G., Izui S. Immunogenetics 49:991-995(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Strain: BXSB, C57BL/6 and MRL. |
| [3] | "Dysregulated expression of the Cd22 gene as a result of a short interspersed nucleotide element insertion in Cd22alpha lupus-prone mice." Mary C., Laporte C., Parzy D., Santiago M.L., Stefani F., Lajaunias F., Parkhouse M.E., O'Keefe T.L., Neuberger M.S., Izui S., Reininger L. J. Immunol. 165:2987-2996(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-178 (ISOFORMS 1; 2 AND 3). Strain: NZW. Tissue: Spleen. |
| [4] | "Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily." Kelm S., Pelz A., Schauer R., Filbin M.T., Tang S., de Bellard M.E., Schnaar R.L., Mahoney J.A., Hartnell A., Bradfield P., Crocker P.R. Curr. Biol. 4:965-972(1994) [PubMed] [Europe PMC] [Abstract] Cited for: SIALIC ACID-BINDING. |
| [5] | "Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes." Chan V.W., Lowell C.A., DeFranco A.L. Curr. Biol. 8:545-553(1998) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION BY LYN. |
| [6] | "Analysis of tyrosine phosphorylation-dependent interactions between stimulatory effector proteins and the B cell co-receptor CD22." Yohannan J., Wienands J., Coggeshall K.M., Justement L.B. J. Biol. Chem. 274:18769-18776(1999) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH GRB2; SYK; PIK3R1/PIK3R2 AND PLCG1, PHOSPHORYLATION AT TYR-777; TYR-822; TYR-837 AND TYR-857, MUTAGENESIS OF TYR-822. |
| [7] | "CD22 forms a quaternary complex with SHIP, Grb2, and Shc. A pathway for regulation of B lymphocyte antigen receptor-induced calcium flux." Poe J.C., Fujimoto M., Jansen P.J., Miller A.S., Tedder T.F. J. Biol. Chem. 275:17420-17427(2000) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH GRB2; SHC1 AND INPP5D, PHOSPHORYLATION BY LYN. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | L16928 mRNA. Translation: AAA02562.1. AF115401 mRNA. Translation: AAD30392.1. AF115400 mRNA. Translation: AAD30391.1. AF102134 mRNA. Translation: AAF02417.1. AJ250676 mRNA. Translation: CAB85609.1. AJ250677 mRNA. Translation: CAB85610.1. AJ250678 mRNA. Translation: CAB85611.1. AJ250679 mRNA. Translation: CAB85612.1. AJ250680 mRNA. Translation: CAB85613.1. AJ250682 mRNA. Translation: CAB85615.1. AJ250683 mRNA. Translation: CAB85616.1. |
| IPI | IPI00117413. IPI00228046. IPI00228047. |
| PIR | A46512. I49583. |
| RefSeq | NP_001036782.1. NM_001043317.2. NP_033975.3. NM_009845.3. |
| UniGene | Mm.260994. |
3D structure databases | |
| ProteinModelPortal | P35329. |
| SMR | P35329. Positions 38-692. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | P35329. 7 interactions. |
PTM databases | |
| PhosphoSite | P35329. |
Proteomic databases | |
| PaxDb | P35329. |
| PRIDE | P35329. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| GeneID | 12483. |
| KEGG | mmu:12483. |
Organism-specific databases | |
| CTD | 933. |
| MGI | MGI:88322. Cd22. |
Phylogenomic databases | |
| eggNOG | NOG287433. |
| HOVERGEN | HBG005272. |
| InParanoid | P35329. |
| KO | K06467. |
| OrthoDB | EOG4C87RQ. |
Gene expression databases | |
| CleanEx | MM_CD22. |
| Genevestigator | P35329. |
| GermOnline | ENSMUSG00000030577. Mus musculus. |
Family and domain databases | |
| Gene3D | 2.60.40.10. 6 hits. |
| InterPro | IPR013162. CD80_C2-set. IPR007110. Ig-like_dom. IPR013783. Ig-like_fold. IPR003599. Ig_sub. IPR003598. Ig_sub2. [Graphical view] |
| Pfam | PF08205. C2-set_2. 1 hit. [Graphical view] |
| SMART | SM00409. IG. 2 hits. SM00408. IGc2. 4 hits. [Graphical view] |
| PROSITE | PS50835. IG_LIKE. 6 hits. [Graphical view] |
| ProtoNet | Search... |
Other | |
| BindingDB | P35329. |
| ChEMBL | CHEMBL1075279. |
| NextBio | 281386. |
| SOURCE | Search... |
Entry information
| Entry name | CD22_MOUSE | ||||||||
| Accession | Primary (citable) accession number: P35329 Secondary accession number(s): Q9JHL2 Q9WU51 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
